
Sai Life Sciences opens state-of-the-art peptide research center
The Peptide Research Center is equipped with automation, robotics, and more. It is designed to support pharmaceutical and biotech innovators with specialized services.
The Peptide Research Center is equipped with automation, robotics, and more. It is designed to support pharmaceutical and biotech innovators with specialized services.
Nearly half of consumers snack three or more times per day.
The hearing aids market is set for significant growth over the next decade, driven by rising awareness, increasing cases of hearing impairment, and continuous technological advancements.
The Consumer Products Engagement report highlights brands' growing challenge in retaining customer loyalty.
GLP-1 therapies emerge as a key driver of industry return on investment.
With the obesity treatment market expected to reach $200 billion by 2031, this study could greatly influence future therapeutic approaches.
Private-label brands are now a primary growth driver for 53% of retailers. Once seen as budget alternatives, they are evolving into premium and innovative choices.
Report reveals orphans’ growth advantage over non-orphans is narrowing, begging the question - are these drugs still a class apart?
“These findings reinforce the impact of innovative partnerships in improving health outcomes,” says the NACDS Foundation president.
However, an undercurrent of mental health threats loom.
“Younger shoppers, particularly Millennials and Gen Z, are driving significant shifts in the produce industry.”
The study's authors stress that misleading promotion of medical tests can lead to overdiagnosis.
NielsenIQ reports that consumers are embracing digital-first wellness solutions at an unprecedented rate.
CoverMyMeds' 2025 Medication Access Report: From Barriers to Bridges calls for increased collaboration and interoperability across the healthcare industry to improve patient outcomes.
In 2025, the number of people without commercial insurance coverage for these medications surged significantly. Zepbound saw a 14% increase since 2024, leaving 4.9 million people without coverage, and Ozempic saw a 22% increase, affecting another 1.1 million people.
Protein snacks reached $24B in sales and are growing at three times the rate of the overall snacking category.